Literature DB >> 15956201

Phenotype-genotype correlation in Hirschsprung disease is illuminated by comparative analysis of the RET protein sequence.

Carl S Kashuk1, Eric A Stone, Elizabeth A Grice, Matthew E Portnoy, Eric D Green, Arend Sidow, Aravinda Chakravarti, Andrew S McCallion.   

Abstract

The ability to discriminate between deleterious and neutral amino acid substitutions in the genes of patients remains a significant challenge in human genetics. The increasing availability of genomic sequence data from multiple vertebrate species allows inclusion of sequence conservation and physicochemical properties of residues to be used for functional prediction. In this study, the RET receptor tyrosine kinase serves as a model disease gene in which a broad spectrum (> or = 116) of disease-associated mutations has been identified among patients with Hirschsprung disease and multiple endocrine neoplasia type 2. We report the alignment of the human RET protein sequence with the orthologous sequences of 12 non-human vertebrates (eight mammalian, one avian, and three teleost species), their comparative analysis, the evolutionary topology of the RET protein, and predicted tolerance for all published missense mutations. We show that, although evolutionary conservation alone provides significant information to predict the effect of a RET mutation, a model that combines comparative sequence data with analysis of physiochemical properties in a quantitative framework provides far greater accuracy. Although the ability to discern the impact of a mutation is imperfect, our analyses permit substantial discrimination between predicted functional classes of RET mutations and disease severity even for a multigenic disease such as Hirschsprung disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956201      PMCID: PMC1157046          DOI: 10.1073/pnas.0503259102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus.

Authors:  S Bolk; A Pelet; R M Hofstra; M Angrist; R Salomon; D Croaker; C H Buys; S Lyonnet; A Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Inference of functional regions in proteins by quantification of evolutionary constraints.

Authors:  Alexander L Simon; Eric A Stone; Arend Sidow
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

3.  Segregation at three loci explains familial and population risk in Hirschsprung disease.

Authors:  Stacey B Gabriel; Rémi Salomon; Anna Pelet; Misha Angrist; Jeanne Amiel; Myriam Fornage; Tania Attié-Bitach; Jane M Olson; Robert Hofstra; Charles Buys; Julie Steffann; Arnold Munnich; Stanislas Lyonnet; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2002-04-15       Impact factor: 38.330

4.  The RET receptor: function in development and dysfunction in congenital malformation.

Authors:  S Manié; M Santoro; A Fusco; M Billaud
Journal:  Trends Genet       Date:  2001-10       Impact factor: 11.639

5.  A structural EM algorithm for phylogenetic inference.

Authors:  Nir Friedman; Matan Ninio; Itsik Pe'er; Tal Pupko
Journal:  J Comput Biol       Date:  2002       Impact factor: 1.479

6.  Amino acid substitutions in the human genome: evolutionary implications of single nucleotide polymorphisms.

Authors:  Jacek Majewski; Jurg Ott
Journal:  Gene       Date:  2003-02-27       Impact factor: 3.688

7.  SIFT: Predicting amino acid changes that affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

8.  Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site.

Authors:  J Anders; S Kjar; C F Ibáñez
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

9.  Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity.

Authors:  Eric A Stone; Arend Sidow
Journal:  Genome Res       Date:  2005-06-17       Impact factor: 9.043

10.  Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease.

Authors:  Minerva M Carrasquillo; Andrew S McCallion; Erik G Puffenberger; Carl S Kashuk; Nassim Nouri; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2002-09-23       Impact factor: 38.330

View more
  14 in total

1.  Hirschsprung's disease and variants in genes that regulate enteric neural crest cell proliferation, migration and differentiation.

Authors:  Tonia C Carter; Denise M Kay; Marilyn L Browne; Aiyi Liu; Paul A Romitti; Devon Kuehn; Mary R Conley; Michele Caggana; Charlotte M Druschel; Lawrence C Brody; James L Mills
Journal:  J Hum Genet       Date:  2012-05-31       Impact factor: 3.172

Review 2.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

3.  ProPhylER: a curated online resource for protein function and structure based on evolutionary constraint analyses.

Authors:  Jonathan Binkley; Kalpana Karra; Andrew Kirby; Midori Hosobuchi; Eric A Stone; Arend Sidow
Journal:  Genome Res       Date:  2009-10-21       Impact factor: 9.043

4.  Identification of a novel variant of the RET proto-oncogene in a novel family with Hirschsprung's disease.

Authors:  Takafumi Kawano; Kazuyoshi Hosomichi; Ituro Inoue; Ryuichi Shimono; Shun Onishi; Kazuhiko Nakame; Tatsuru Kaji; Hiroshi Matsufuji; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2017-08-10       Impact factor: 1.827

5.  Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability.

Authors:  Eileen Sproat Emison; Merce Garcia-Barcelo; Elizabeth A Grice; Francesca Lantieri; Jeanne Amiel; Grzegorz Burzynski; Raquel M Fernandez; Li Hao; Carl Kashuk; Kristen West; Xiaoping Miao; Paul K H Tam; Paola Griseri; Isabella Ceccherini; Anna Pelet; Anne-Sophie Jannot; Loic de Pontual; Alexandra Henrion-Caude; Stanislas Lyonnet; Joke B G M Verheij; Robert M W Hofstra; Guillermo Antiñolo; Salud Borrego; Andrew S McCallion; Aravinda Chakravarti
Journal:  Am J Hum Genet       Date:  2010-07-09       Impact factor: 11.025

Review 6.  Hirschsprung's disease: clinical dysmorphology, genes, micro-RNAs, and future perspectives.

Authors:  Consolato Maria Sergi; Oana Caluseriu; Hunter McColl; David D Eisenstat
Journal:  Pediatr Res       Date:  2016-09-28       Impact factor: 3.756

7.  Male and female differential reproductive rate could explain parental transmission asymmetry of mutation origin in Hirschsprung disease.

Authors:  Anne-Sophie Jannot; Jeanne Amiel; Anna Pelet; Francesca Lantieri; Raquel M Fernandez; Joke B G M Verheij; Merce Garcia-Barcelo; Stacey Arnold; Isabella Ceccherini; Salud Borrego; Robert M W Hofstra; Paul K H Tam; Arnold Munnich; Aravinda Chakravarti; Françoise Clerget-Darpoux; Stanislas Lyonnet
Journal:  Eur J Hum Genet       Date:  2012-03-07       Impact factor: 4.246

8.  Mammal-restricted elements predispose human RET to folding impairment by HSCR mutations.

Authors:  Svend Kjaer; Sarah Hanrahan; Nick Totty; Neil Q McDonald
Journal:  Nat Struct Mol Biol       Date:  2010-05-16       Impact factor: 15.369

9.  Domain duplication, divergence, and loss events in vertebrate Msx paralogs reveal phylogenomically informed disease markers.

Authors:  John R Finnerty; Maureen E Mazza; Peter A Jezewski
Journal:  BMC Evol Biol       Date:  2009-01-20       Impact factor: 3.260

10.  Two alleles of NF-kappaB in the sea anemone Nematostella vectensis are widely dispersed in nature and encode proteins with distinct activities.

Authors:  James C Sullivan; Francis S Wolenski; Adam M Reitzel; Courtney E French; Nikki Traylor-Knowles; Thomas D Gilmore; John R Finnerty
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.